NIHR Moorfields Biomedical Research Centre, London, UK.
Institute of Ophthalmology, University College London, London, UK.
BMJ Open. 2024 May 21;14(5):e081998. doi: 10.1136/bmjopen-2023-081998.
To assess whether patients from minority ethnic groups have different perceptions about the quality-of-life outcomes that matter most to them.
Cross-sectional observational study.
High volume eye centres serving the most ethnically diverse region in the UK, recruiting from July 2021 to February 2022.
511 patients with primary open-angle glaucoma and the predisease state of ocular hypertension.
The main outcome was participants' self-reported priorities for health outcomes.
Participants fell into one of four clusters with differing priorities for health outcomes, namely: (1) vision, (2) drop freedom, (3) intraocular pressure and (4) one-time treatment. Ethnicity was the strongest determinant of cluster membership after adjusting for potential confounders. Compared with white patients prioritising vision alone, the OR for black/black British patients was 7.31 (95% CI 3.43 to 15.57, p<0.001) for prioritising drop freedom; 5.95 (2.91 to 12.16, p<0.001) for intraocular pressure; and 2.99 (1.44 to 6.18, p=0.003) for one-time treatment. For Asian/Asian British patients, the OR was 3.17 (1.12 to 8.96, p=0.030) for prioritising intraocular pressure as highly as vision. Other ethnic minority groups also had higher ORs for prioritising health outcomes other than vision alone: 4.50 (1.03 to 19.63, p=0.045) for drop freedom and 5.37 (1.47 to 19.60, p=0.011) for intraocular pressure.
Ethnicity is strongly associated with differing perceptions about the health outcomes that matter. An individualised and ethnically inclusive approach is needed when selecting and evaluating treatments in clinical and research settings.
评估少数民族患者对最重要的生活质量结果的看法是否不同。
横断面观察性研究。
为英国种族最多样化的地区提供服务的大容量眼科中心,于 2021 年 7 月至 2022 年 2 月招募患者。
511 名原发性开角型青光眼和眼病高血压前期患者。
主要结局为参与者自我报告的健康结果优先事项。
参与者分为四个具有不同健康结果优先事项的聚类,分别是:(1)视力,(2)滴药自由,(3)眼内压和(4)一次性治疗。在调整潜在混杂因素后,种族是聚类成员身份的最强决定因素。与仅优先考虑视力的白人患者相比,黑人和英裔黑人患者优先考虑滴药自由的优势比为 7.31(95%CI 3.43 至 15.57,p<0.001);优先考虑眼内压的优势比为 5.95(2.91 至 12.16,p<0.001);优先考虑一次性治疗的优势比为 2.99(1.44 至 6.18,p=0.003)。对于亚裔/英裔亚裔患者,优先考虑眼内压与视力同等重要的优势比为 3.17(1.12 至 8.96,p=0.030)。其他少数族裔群体也有更高的优势比,优先考虑除视力以外的健康结果:优先考虑滴药自由的优势比为 4.50(1.03 至 19.63,p=0.045);优先考虑眼内压的优势比为 5.37(1.47 至 19.60,p=0.011)。
种族与对重要健康结果的不同看法密切相关。在临床和研究环境中选择和评估治疗方法时,需要采用个体化和包容少数民族的方法。